Publications by authors named "Michael Varvenne"

Claim this Profile
A
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial.
Thorsten O Goetze, Alexander Reichart, Ulli S Bankstahl, Claudia Pauligk, Maria Loose, Michael Varvenne

Ann Surg Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease.
Michael Stadler, Lothar Hambach, Elke Dammann, Helmut Diedrich, Haytham Kamal, Michael Varvenne

Ann Hematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function.
Arijit Biswas, Vytautas Ivaskevicius, Anne Thomas, Michael Varvenne, Brigitte Brand

Ann Hematol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients.
Cristina Solomon, Janne Cadamuro, Bernhard Ziegler, Herbert Schöchl, Michael Varvenne

Transfusion· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of immunomodulatory drugs on the cytotoxicity induced by monoclonal antibody 17-1A and interleukin-2.
Dimitri Flieger, Michael Varvenne, Rolf Kleinschmidt, Ingo G H Schmidt-Wolf

Cell Immunol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis